Figure 3: (A) After five and (B) seven months with antitubercular therapy, despite severe scleral thinning with uveal exposure, the eye remains quiet with no inflammation.
Figure 3: (A) After five and (B) seven months with antitubercular therapy, despite severe scleral thinning with uveal exposure, the eye remains quiet with no inflammation.